Wolverine Trading
TXMD icon

Wolverine Trading’s TherapeuticsMD TXMD Stock Holding History

Wolverine Trading’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-461
Closed -$20.5K – 6989
2021
Q2 		$27K Sell
461
-180
-28% -$10.9K ﹤0.01% 5673
2021
Q1 		$43K Buy
+641
New +$50.2K ﹤0.01% 5678
2020
Q4 		– Sell
-414
Closed -$33K – 5499
2020
Q3 		$33K Sell
414
-359
-46% -$28.6K ﹤0.01% 4336
2020
Q2 		$46K Sell
773
-114
-13% -$6.64K ﹤0.01% 4324
2020
Q1 		$47K Buy
887
+634
+251% +$62.9K ﹤0.01% 4282
2019
Q4 		$30K Sell
253
-51
-17% -$7.33K ﹤0.01% 4531
2019
Q3 		$58K Buy
+304
New +$42.9K ﹤0.01% 4022
2019
Q2 		– Sell
-1,187
Closed -$289K – 5155
2019
Q1 		$289K Buy
1,187
+984
+485% +$260K ﹤0.01% 3404
2018
Q4 		$40K Sell
203
-925
-82% -$226K ﹤0.01% 4204
2018
Q3 		$370K Sell
1,128
-62
-5% -$19K ﹤0.01% 3476
2018
Q2 		$290K Hold
1,190
– – ﹤0.01% 3824
2018
Q1 		$290K Buy
1,190
+875
+278% +$245K ﹤0.01% 3824
2017
Q4 		$95K Buy
+315
New +$87.7K ﹤0.01% 4470

Other funds holding TXMD

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
SMH
Sanders Morris Harris Houston, Texas $172M AUM 22.54% 1-Year Est. Return
SFI
Susquehanna Fundamental Investments Bala Cynwyd, Pennsylvania $2.67B AUM 21.74% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return

Wolverine Trading's TXMD Position: Q3 2021 in Review

Wolverine Trading sold out of TherapeuticsMD (TXMD) in Q3 2021, closing a stake of 461 shares — an estimated $20.5K sold.

Wolverine Trading first reported a position in TXMD in Q4 2017 and held it in 13 quarters. The position peaked at $370K in Q3 2018. 149 funds tracked by Wall St. Rank hold TXMD as of Q3 2021.

  • Wolverine Trading reported no remaining TherapeuticsMD position as of Q3 2021 after selling out during the quarter.
  • Wolverine Trading sold 461 TherapeuticsMD shares in Q3 2021, an estimated $20.5K.
  • Wolverine Trading first reported a position in TherapeuticsMD in Q4 2017 and held it in 13 quarters.
  • Wolverine Trading's TherapeuticsMD position peaked at $370K in Q3 2018.
  • 149 funds tracked by Wall St. Rank held TherapeuticsMD as of Q3 2021.

Based on Wolverine Trading's 13F filing for Q3 2021, filed 12 Nov 2021.